Jason R. Smith, ScM; Alison R. Huang, PhD, MPH; Yunshu Zhou, MS; et al.
JAMA Ophthalmol. 2024;142(10):900-908. doi:10.1001/jamaophthalmol.2024.3131
This cross-sectional study evaluates population attributable fractions of dementia by vision impairment.
-
Invited Commentary
Vision Impairment in Dementia—A Growing Priority for Prevention
Mingguang He, MD, PhD; Xianwen Shang, PhD
JAMA Ophthalmol
Health and the 2024 US Election
Eric Sherman, MD; Leslie M. Niziol, MS; Patrice M. Hicks, PhD, MPH; et al.
JAMA Ophthalmol. 2024;142(10):909-916. doi:10.1001/jamaophthalmol.2024.3132
This cross-sectional study examines the use of free eye care services for screening to identify eye disease.
-
Invited Commentary
Bringing Eye Care to the People
John S. Wittenborn, BS; David B. Rein, PhD
JAMA Ophthalmol
Yangfan Yang, MD, PhD; Kezheng Xu, MM; Zidong Chen, MD, PhD; et al.
JAMA Ophthalmol. 2024;142(10):918-924. doi:10.1001/jamaophthalmol.2024.3133
This post hoc analysis of a randomized clinical trial evaluates the responsiveness of open-angle glaucoma and ocular hypertension to selective laser trabeculoplasty.
-
Invited Commentary
Repeat Selective Laser Trabeculoplasty and Open-Angle Glaucoma
Jacob A. Kanter, MD; Harry A. Quigley, MD
JAMA Ophthalmol
Qais A. Dihan, BS; Ahmad F. Alzein, BS; Othman M. Ibrahim, BS; et al.
JAMA Ophthalmol. 2024;142(10):926-933. doi:10.1001/jamaophthalmol.2024.3281
This cross-sectional study evaluates racial, ethnic, and sex representation in Pediatric Eye Disease Investigator Group clinical studies from 1997 to 2022 compared with the 2010 US Census pediatric population.
-
Invited Commentary
Racial and Ethnic Disparities in Pediatric Ophthalmology Research
Megan E. Collins, MD, MPH; Adrienne W. Scott, MD
JAMA Ophthalmol
Mae O. Gordon, PhD; Feng Gao, PhD; John Burkland, BS; et al.
JAMA Ophthalmol. 2024;142(10):935-942. doi:10.1001/jamaophthalmol.2024.3282
This cross-sectional study used 20-year follow-up data from the Ocular Hypertension Treatment Study to determine the impact, if any, of preperimetric glaucoma and early glaucomatous visual field loss on patients’ self-reported vision-related quality of life compared with participants who did not develop glaucoma.
Young In Shin, MD; Jaekyoung Lee, MD; Yoon Jeong, MD; et al.
JAMA Ophthalmol. 2024;142(10):943-950. doi:10.1001/jamaophthalmol.2024.3323
This study attempts to determine the association of the proximal location of disc hemorrhage with glaucoma progression.
-
Invited Commentary
Disc Hemorrhages in Open-Angle Glaucoma—Between a Rock and a Hard Place?
Alice Verticchio Vercellin, MD, PhD; Louis R. Pasquale, MD; Alon Harris, MS, PhD
JAMA Ophthalmol
Susan B. Bressler, MD; Abhijit Barve, MD, PhD; Prasanna C. Ganapathi, MD; et al.
open access
JAMA Ophthalmol. 2024;142(10):952-960. doi:10.1001/jamaophthalmol.2024.3458
This randomized clinical trial investigates the efficacy and safety of aflibercept biosimilar MYL-1701P compared with reference aflibercept for the treatment of diabetic macular edema (DME).
Azraa S. Chaudhury, MD; Maryam Ige, MD; Shikha Marwah, PhD, MS; et al.
JAMA Ophthalmol. 2024;142(10):961-970. doi:10.1001/jamaophthalmol.2024.3528
This cohort study examines data for Black and White patients with diabetes at 11 US medical centers to compare rates of receiving guideline-recommended eye care in relation to social determinants of health and such factors as health insurance type, residence urbanicity, diabetes type, and diabetic retinopathy.
-
Invited Commentary
Socioeconomic Determinants in Diabetic Retinopathy Screening
Asadolah Movahedan, MD; Keith J. Wroblewski, MD
JAMA Ophthalmol